首页 > 最新文献

Chirurgia最新文献

英文 中文
Unstable Pelvic Ring Fractures: From Bleeding Control to Bone Repair Along the Trauma Pathway. 不稳定骨盆环骨折:从出血控制到沿创伤途径的骨修复。
IF 0.8 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.21614/chirurgia.3217
Kayaththery Varathan, Adele Zacken, Mustafa Albayati, Vishwajeet Singh, Uzair Khan, Janusha Ganesthasan, Shanmukha Koppolu, Havil Stephen Alexander, Ruqaiya Al-Habsi

Unstable pelvic ring fractures pose significant clinical challenges due to their intricate anatomy, substantial bleeding risk and frequent involvement of multiple organ systems. In the prehospital setting, early haemorrhage control with pre-peritoneal pelvic packing (PPP) and angioembolisation (AE) is critical: PPP rapidly controls venous bleeding, while AE targets arterial sources. Following initial resuscitation, timely bone repair with temporary external fixation (ExFix) and definitive bone repair, with open reduction and internal fixation (ORIF), is vital in minimising long-term complications. Hence, to coordinate these approaches from prehospital care to surgical intervention, a multidisciplinary approach is required along the trauma pathway. Advancements in trauma network systems may also offer improvements in survival and functional recovery. Therefore, this literature review critically evaluates the indications, timing and synergistic use of PPP, AE, ExFix and ORIF to optimise outcomes for patients with unstable pelvic ring fractures.

不稳定骨盆环骨折由于其复杂的解剖结构、大量出血风险和频繁累及多器官系统,给临床带来了重大挑战。在院前环境中,通过腹膜前盆腔填充物(PPP)和血管栓塞(AE)进行早期出血控制至关重要:PPP可快速控制静脉出血,而AE可靶向动脉出血。在最初的复苏后,及时用临时外固定(ExFix)和最终骨修复(开放复位内固定(ORIF))进行骨修复对于减少长期并发症至关重要。因此,为了协调从院前护理到手术干预的这些方法,需要沿着创伤途径采取多学科方法。创伤网络系统的进步也可能提供生存和功能恢复的改善。因此,本文献综述严格评估了PPP、AE、ExFix和ORIF的适应症、时机和协同使用,以优化不稳定骨盆环骨折患者的预后。
{"title":"Unstable Pelvic Ring Fractures: From Bleeding Control to Bone Repair Along the Trauma Pathway.","authors":"Kayaththery Varathan, Adele Zacken, Mustafa Albayati, Vishwajeet Singh, Uzair Khan, Janusha Ganesthasan, Shanmukha Koppolu, Havil Stephen Alexander, Ruqaiya Al-Habsi","doi":"10.21614/chirurgia.3217","DOIUrl":"https://doi.org/10.21614/chirurgia.3217","url":null,"abstract":"<p><p>Unstable pelvic ring fractures pose significant clinical challenges due to their intricate anatomy, substantial bleeding risk and frequent involvement of multiple organ systems. In the prehospital setting, early haemorrhage control with pre-peritoneal pelvic packing (PPP) and angioembolisation (AE) is critical: PPP rapidly controls venous bleeding, while AE targets arterial sources. Following initial resuscitation, timely bone repair with temporary external fixation (ExFix) and definitive bone repair, with open reduction and internal fixation (ORIF), is vital in minimising long-term complications. Hence, to coordinate these approaches from prehospital care to surgical intervention, a multidisciplinary approach is required along the trauma pathway. Advancements in trauma network systems may also offer improvements in survival and functional recovery. Therefore, this literature review critically evaluates the indications, timing and synergistic use of PPP, AE, ExFix and ORIF to optimise outcomes for patients with unstable pelvic ring fractures.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 eCollection","pages":"1-8"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145630328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Quality of Life in Gastric Cancer Patients Undergoing Different Surgical Reconstruction Methods. A Comparative Study using the EORTC QLQ-STO22 Questionnaire. 不同手术重建方式胃癌患者生活质量评价。使用EORTC QLQ-STO22问卷的比较研究。
IF 0.8 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.21614/chirurgia.3203
Catalin Cosma, Vlad Olimpiu Butiurca, Cosmin Nicolescu, Paul Cristian Russu, Marian Botoncea, Calin Molnar

Background: Gastric cancer remains a major global health burden. Beyond oncologic outcomes, health-related quality of life (HRQoL) is increasingly recognized as a critical endpoint influenced by the reconstruction method after gastrectomy.

Methods: A prospective observational study was conducted between December 2021 and December 2024 at the Emergency County Hospital of Targu Mures, Romania, including 150 patients undergoing curative-intent gastrectomy. Patients were divided into two groups: gastroduodenal anastomosis (Billroth I, n=72) and gastrojejunal anastomosis (Billroth II/Roux-en-Y, n = 78). HRQoL was assessed using the EORTC QLQ-STO22 preoperatively and at 3 and 6 months postoperatively. Scores were linearly transformed to a 0 - 100 scale. Statistical analysis was performed with EasyMedStat

Results: The mean age was 61 years, with similar baseline characteristics. Postoperative complications occurred in 32.0% of patients, mostly grade I - II. Both groups showed deterioration in dysphagia, pain, reflux, and anxiety at 3 months, followed by partial recovery at 6 months. Reflux scores were consistently higher in the gastrojejunal group at all timepoints (baseline 26.1 vs. 17.6; 3 months 36.5 vs. 24.5; 6 months 27.2 vs. 14.7; p 0.001). Eating restrictions were also greater at 3 and 6 months.

Conclusions: Both reconstruction methods impair short-term HRQoL, with partial recovery by 6 months. Gastrojejunal reconstruction is associated with higher reflux and eating restrictions, whereas gastroduodenal reconstruction shows more favorable functional outcomes.

背景:胃癌仍然是一个主要的全球健康负担。除肿瘤预后外,与健康相关的生活质量(HRQoL)越来越被认为是受胃切除术后重建方法影响的关键终点。方法:一项前瞻性观察研究于2021年12月至2024年12月在罗马尼亚Targu Mures急诊县医院进行,包括150名接受治疗性胃切除术的患者。患者分为胃十二指肠吻合组(Billroth I, n=72)和胃空肠吻合组(Billroth II/Roux-en-Y, n= 78)。术前、术后3个月、6个月采用EORTC QLQ-STO22评估HRQoL。分数线性转换为0 - 100分。使用EasyMedStatResults进行统计分析:平均年龄为61岁,基线特征相似。术后并发症发生率为32.0%,以I - II级为主。两组在3个月时均出现吞咽困难、疼痛、反流和焦虑的恶化,6个月时部分恢复。胃空肠组在所有时间点的反流评分均较高(基线26.1比17.6;3个月36.5比24.5;6个月27.2比14.7;p 0.001)。在3个月和6个月时,饮食限制也更严格。结论:两种重建方法均影响短期HRQoL, 6个月后部分恢复。胃空肠重建与较高的反流和进食限制有关,而胃十二指肠重建显示更有利的功能结果。
{"title":"Evaluation of Quality of Life in Gastric Cancer Patients Undergoing Different Surgical Reconstruction Methods. A Comparative Study using the EORTC QLQ-STO22 Questionnaire.","authors":"Catalin Cosma, Vlad Olimpiu Butiurca, Cosmin Nicolescu, Paul Cristian Russu, Marian Botoncea, Calin Molnar","doi":"10.21614/chirurgia.3203","DOIUrl":"10.21614/chirurgia.3203","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer remains a major global health burden. Beyond oncologic outcomes, health-related quality of life (HRQoL) is increasingly recognized as a critical endpoint influenced by the reconstruction method after gastrectomy.</p><p><strong>Methods: </strong>A prospective observational study was conducted between December 2021 and December 2024 at the Emergency County Hospital of Targu Mures, Romania, including 150 patients undergoing curative-intent gastrectomy. Patients were divided into two groups: gastroduodenal anastomosis (Billroth I, n=72) and gastrojejunal anastomosis (Billroth II/Roux-en-Y, n = 78). HRQoL was assessed using the EORTC QLQ-STO22 preoperatively and at 3 and 6 months postoperatively. Scores were linearly transformed to a 0 - 100 scale. Statistical analysis was performed with EasyMedStat</p><p><strong>Results: </strong>The mean age was 61 years, with similar baseline characteristics. Postoperative complications occurred in 32.0% of patients, mostly grade I - II. Both groups showed deterioration in dysphagia, pain, reflux, and anxiety at 3 months, followed by partial recovery at 6 months. Reflux scores were consistently higher in the gastrojejunal group at all timepoints (baseline 26.1 vs. 17.6; 3 months 36.5 vs. 24.5; 6 months 27.2 vs. 14.7; p 0.001). Eating restrictions were also greater at 3 and 6 months.</p><p><strong>Conclusions: </strong>Both reconstruction methods impair short-term HRQoL, with partial recovery by 6 months. Gastrojejunal reconstruction is associated with higher reflux and eating restrictions, whereas gastroduodenal reconstruction shows more favorable functional outcomes.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 Ahead of print","pages":"1-11"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145539339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphadenectomy Indications in Endometrial Cancer. A Surgeon's Dilemma in the Era of Perpetual Changes. 子宫内膜癌的淋巴结切除指征。一个外科医生在永恒变化时代的困境。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3216
Ioana-Maria Ignat, Corina-Elena Minciuna, Romina-Marina Sima, Liana Ples, Mircea Octavian Poenaru, Andrei Diaconescu, Catalin Vasilescu

Background: The role of lymphadenectomy in endometrial cancer has long been debated. Once considered to have prognostic and therapeutic value, it is now evident that balancing accurate staging with procedure-related morbidity remains a challenge. Objective: This review aims to clarify the current indications for systematic lymphadenectomy in endometrial carcinoma, integrating the updated FIGO 2023 staging system, the ESGOESTRO- ESP 2025 guidelines, and the emerging role of molecular classification. Methods: We analyzed landmark randomized controlled trials, updated guideline recommendations, and the evolving paradigm of sentinel lymph node (SLN) mapping, with emphasis on risk stratification based on histology, grade, lymphovascular space invasion (LVSI), and molecular features. Results: High-level evidence demonstrated that systematic lymphadenectomy does not improve survival in early-stage disease, while significantly increasing morbidity. Current guidelines remain complex, but consistently emphasize SLN mapping as the preferred method of nodal assessment. Systematic lymphadenectomy is no longer justified as routine; it is reserved for high-intermediate and high-risk patients when SLN mapping fails, performed as side-specific dissection. In advanced disease, the surgical goal is complete cytoreduction, with selective removal of bulky or suspicious nodes; systematic lymphadenectomy must not be performed in stages III-IV. Conclusion: The paradigm has shifted from universal lymphadenectomy to a tailored, risk-adapted approach. SLN biopsy represents the new standard, reducing morbidity without compromising oncologic outcomes. Expanding access to molecular profiling, still limited in Romania, is crucial for better oncological results and alignment with European standards.

背景:淋巴结切除术在子宫内膜癌中的作用一直存在争议。一旦被认为具有预后和治疗价值,现在很明显,平衡准确的分期与手术相关的发病率仍然是一个挑战。目的:本综述旨在结合最新的FIGO 2023分期系统、ESGOESTRO- ESP 2025指南以及分子分类的新作用,阐明目前子宫内膜癌系统性淋巴结切除术的适应症。方法:我们分析了具有里程碑意义的随机对照试验、最新的指南建议和前哨淋巴结(SLN)定位的发展模式,重点是基于组织学、分级、淋巴血管间隙浸润(LVSI)和分子特征的风险分层。结果:高水平的证据表明,系统性淋巴结切除术并不能提高早期疾病的生存率,反而会显著增加发病率。目前的指南仍然很复杂,但始终强调SLN映射是节点评估的首选方法。系统淋巴结切除术不再是常规的;当SLN定位失败时,保留用于高、中、高风险患者,作为侧特异性解剖。在疾病晚期,手术目标是完全减少细胞,选择性切除大块或可疑的淋巴结;系统淋巴结切除术不能在III-IV期进行。结论:范式已经从普遍的淋巴结切除术转变为量身定制的,风险适应的方法。SLN活检代表了新的标准,在不影响肿瘤预后的情况下降低了发病率。扩大分子谱分析在罗马尼亚仍然有限,这对于更好的肿瘤学结果和与欧洲标准保持一致至关重要。
{"title":"Lymphadenectomy Indications in Endometrial Cancer. A Surgeon's Dilemma in the Era of Perpetual Changes.","authors":"Ioana-Maria Ignat, Corina-Elena Minciuna, Romina-Marina Sima, Liana Ples, Mircea Octavian Poenaru, Andrei Diaconescu, Catalin Vasilescu","doi":"10.21614/chirurgia.3216","DOIUrl":"10.21614/chirurgia.3216","url":null,"abstract":"<p><p><b>Background:</b> The role of lymphadenectomy in endometrial cancer has long been debated. Once considered to have prognostic and therapeutic value, it is now evident that balancing accurate staging with procedure-related morbidity remains a challenge. Objective: This review aims to clarify the current indications for systematic lymphadenectomy in endometrial carcinoma, integrating the updated FIGO 2023 staging system, the ESGOESTRO- ESP 2025 guidelines, and the emerging role of molecular classification. \u0000<b>Methods:</b> We analyzed landmark randomized controlled trials, updated guideline recommendations, and the evolving paradigm of sentinel lymph node (SLN) mapping, with emphasis on risk stratification based on histology, grade, lymphovascular space invasion (LVSI), and molecular features. \u0000<b>Results:</b> High-level evidence demonstrated that systematic lymphadenectomy does not improve survival in early-stage disease, while significantly increasing morbidity. Current guidelines remain complex, but consistently emphasize SLN mapping as the preferred method of nodal assessment. Systematic lymphadenectomy is no longer justified as routine; it is reserved for high-intermediate and high-risk patients when SLN mapping fails, performed as side-specific dissection. In advanced disease, the surgical goal is complete cytoreduction, with selective removal of bulky or suspicious nodes; systematic lymphadenectomy must not be performed in stages III-IV. \u0000<b>Conclusion:</b> The paradigm has shifted from universal lymphadenectomy to a tailored, risk-adapted approach. SLN biopsy represents the new standard, reducing morbidity without compromising oncologic outcomes. Expanding access to molecular profiling, still limited in Romania, is crucial for better oncological results and alignment with European standards.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"519-528"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sentinel Lymph Node Mapping in Endometrial Cancer: Our Initial Experience in a Resource Limited Setting. 子宫内膜癌前哨淋巴结定位:我们在资源有限的情况下的初步经验。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3155
Szilárd Leó Kiss, Mihai Stanca, Dan Mihai Căpîlnă, Tudor Emil Căpîlnă, Maria Pop-Suciu, Botond Istvan Kiss, Szilárd Leó Kiss, Mihai Emil Căpîlnă

Background: Nodal status is one of the most important prognostic factors in endometrial cancer (EC), but systematic lymphadenectomy is associated with significant morbidity. Sentinel lymph node (SLN) mapping offers a less invasive alternative. However, data are limited where indocyanine green is unavailable. Methods: Between November 2019 and March 2025, 29 women with FIGO stage Iâ?"III EC were prospectively enrolled in this study. Cervical injection of methylene blue, with or without technetium-99m, was used for SLN mapping. Ultrastaging was performed routinely. In patients with high-risk disease, full pelvic and para-aortic lymphadenectomy was also performed. Detection rates, sensitivity, and negative predictive value (NPV) were calculated. Results: Overall and bilateral detection rates were 75% and 48%, respectively (methylene blue: 72% / 44%; dual tracer: 100% / 75%). Nodal metastases were identified in 9 of 29 patients (31%). Patient-level sensitivity was 71%, with an NPV of 88%. Application of the side-specific completion algorithm increased sensitivity to 86%. Side-specific sensitivity and NPV reached 100%. Lymphovascular space invasion and 50% myometrial invasion were significantly associated with nodal metastasis (p 0.05). No mapping-related complications were observed. Conclusions: SLN mapping with methylene blue, with or without technetium, combined with a side-specific completion algorithm, enables reliable nodal staging even without fluorescence imaging.

背景:淋巴结状态是子宫内膜癌(EC)最重要的预后因素之一,但系统性淋巴结切除术与显著的发病率相关。前哨淋巴结(SLN)定位提供了一种侵入性较小的选择。然而,在无法获得吲哚菁绿的情况下,数据有限。方法:2019年11月至2025年3月,29例FIGO期IÃⅱ?III名EC被前瞻性地纳入了这项研究。宫颈注射亚甲蓝(含或不含锝-99m)进行SLN定位。常规进行超存储。对于高危患者,也行全盆腔和腹主动脉旁淋巴结切除术。计算检出率、敏感性和阴性预测值(NPV)。结果:总检出率为75%,双侧检出率为48%(亚甲蓝:72% / 44%;双示踪剂:100% / 75%)。29例患者中有9例(31%)存在淋巴结转移。患者水平的敏感性为71%,NPV为88%。应用特定侧面完井算法,灵敏度提高到86%。侧特异性灵敏度和NPV均达到100%。淋巴血管间隙浸润和50%肌层浸润与淋巴结转移有显著相关性(p < 0.05)。未观察到与定位相关的并发症。结论:亚甲基蓝SLN定位,有或没有锝,结合侧特异性完成算法,即使没有荧光成像,也能实现可靠的淋巴结分期。
{"title":"Sentinel Lymph Node Mapping in Endometrial Cancer: Our Initial Experience in a Resource Limited Setting.","authors":"Szilárd Leó Kiss, Mihai Stanca, Dan Mihai Căpîlnă, Tudor Emil Căpîlnă, Maria Pop-Suciu, Botond Istvan Kiss, Szilárd Leó Kiss, Mihai Emil Căpîlnă","doi":"10.21614/chirurgia.3155","DOIUrl":"10.21614/chirurgia.3155","url":null,"abstract":"<p><p><b>Background:</b> Nodal status is one of the most important prognostic factors in endometrial cancer (EC), but systematic lymphadenectomy is associated with significant morbidity. Sentinel lymph node (SLN) mapping offers a less invasive alternative. However, data are limited where indocyanine green is unavailable. \u0000<b>Methods:</b> Between November 2019 and March 2025, 29 women with FIGO stage Iâ?\"III EC were prospectively enrolled in this study. Cervical injection of methylene blue, with or without technetium-99m, was used for SLN mapping. Ultrastaging was performed routinely. In patients with high-risk disease, full pelvic and para-aortic lymphadenectomy was also performed. Detection rates, sensitivity, and negative predictive value (NPV) were calculated. \u0000<b>Results:</b> Overall and bilateral detection rates were 75% and 48%, respectively (methylene blue: 72% / 44%; dual tracer: 100% / 75%). Nodal metastases were identified in 9 of 29 patients (31%). Patient-level sensitivity was 71%, with an NPV of 88%. Application of the side-specific completion algorithm increased sensitivity to 86%. Side-specific sensitivity and NPV reached 100%. Lymphovascular space invasion and 50% myometrial invasion were significantly associated with nodal metastasis (p 0.05). No mapping-related complications were observed. \u0000<b>Conclusions:</b> SLN mapping with methylene blue, with or without technetium, combined with a side-specific completion algorithm, enables reliable nodal staging even without fluorescence imaging.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"529-537"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Pelvic Organ and Rectal Prolapse: A Narrative Review of Surgical Perspectives. 并发盆腔器官和直肠脱垂:外科观点的叙述回顾。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3210
Marian Botoncea, Călin Molnar, Cosmin Lucian Nicolescu, Catalin Dumintru Cosma, Vlad Olimpiu Butiurca, Dragoş Călin Molnar, Claudiu Varlam Molnar

Pelvic organ prolapse (POP) and rectal prolapse (RP) frequently co-occur as manifestations of global pelvic floor dysfunction. This narrative review (January 1, 2015, to August 1, 2025) synthesizes research on the evaluation and surgical management of concurrent disease, emphasizing symptom mapping, standardized examination, and dynamic magnetic resonance defecography (DMRD) - guided phenotyping. Across retrospective series and small prospective studies, single-session, minimally invasive repair - most commonly sacrocolpopexy (Ã+- hysteropexy) with ventral rectopexy - appears feasible in well-selected patients, with perioperative morbidity similar to that in isolated procedures and consistent improvements in bulge symptoms, obstructed defecation, and quality of life. Key principles include multidisciplinary planning, nerve-sparing ventral dissection, non-overlapping meshes with complete peritonealization, and enhanced-recovery pathways. Mesh complications after rectopexy are uncommon. Across recent series, 30-day readmission rates are approximately 2-3%, and early recurrence rates are about 10% for rectal prolapse and 5-8% for apical prolapse at roughly 1-2 years; moreover, a meta-analysis of 16,471 patients found no increase in short-term complications with concomitant repair. Overall, despite encouraging outcomes, heterogeneity, selection bias, and limited follow-up constrain certainty. Higher-quality comparative and long-term studies are needed to refine indications and establish long-term effectiveness.

盆腔器官脱垂(POP)和直肠脱垂(RP)经常作为盆底功能障碍的表现同时发生。本综述(2015年1月1日至2025年8月1日)综合了并发疾病的评估和手术治疗方面的研究,强调了症状定位、标准化检查和动态磁共振排粪图(DMRD)引导的表型分析。在回顾性系列研究和小型前瞻性研究中,单次微创修复——最常见的是骶阴道固定术(Ã+子宫固定术)和腹侧直肠固定术——在经过筛选的患者中似乎是可行的,围手术期发病率与孤立手术相似,并且在肿胀症状、排便障碍和生活质量方面持续改善。主要原则包括多学科计划、保留神经的腹侧解剖、完全腹膜化的非重叠网和增强的恢复途径。直肠固定术后补片并发症并不常见。在最近的一系列研究中,30天的再入院率约为2-3%,直肠脱垂的早期复发率约为10%,根尖脱垂的早期复发率约为5-8%。此外,一项对16,471例患者的荟萃分析发现,伴随修复的短期并发症没有增加。总的来说,尽管结果令人鼓舞,但异质性、选择偏倚和有限的随访限制了确定性。需要更高质量的比较和长期研究来完善适应症和建立长期有效性。
{"title":"Concurrent Pelvic Organ and Rectal Prolapse: A Narrative Review of Surgical Perspectives.","authors":"Marian Botoncea, Călin Molnar, Cosmin Lucian Nicolescu, Catalin Dumintru Cosma, Vlad Olimpiu Butiurca, Dragoş Călin Molnar, Claudiu Varlam Molnar","doi":"10.21614/chirurgia.3210","DOIUrl":"https://doi.org/10.21614/chirurgia.3210","url":null,"abstract":"<p><p>Pelvic organ prolapse (POP) and rectal prolapse (RP) frequently co-occur as manifestations of global pelvic floor dysfunction. This narrative review (January 1, 2015, to August 1, 2025) synthesizes research on the evaluation and surgical management of concurrent disease, emphasizing symptom mapping, standardized examination, and dynamic magnetic resonance defecography (DMRD) - guided phenotyping. Across retrospective series and small prospective studies, single-session, minimally invasive repair - most commonly sacrocolpopexy (Ã+- hysteropexy) with ventral rectopexy - appears feasible in well-selected patients, with perioperative morbidity similar to that in isolated procedures and consistent improvements in bulge symptoms, obstructed defecation, and quality of life. Key principles include multidisciplinary planning, nerve-sparing ventral dissection, non-overlapping meshes with complete peritonealization, and enhanced-recovery pathways. Mesh complications after rectopexy are uncommon. Across recent series, 30-day readmission rates are approximately 2-3%, and early recurrence rates are about 10% for rectal prolapse and 5-8% for apical prolapse at roughly 1-2 years; moreover, a meta-analysis of 16,471 patients found no increase in short-term complications with concomitant repair. Overall, despite encouraging outcomes, heterogeneity, selection bias, and limited follow-up constrain certainty. Higher-quality comparative and long-term studies are needed to refine indications and establish long-term effectiveness.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"502-510"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathological Profile of Prostatic Lesions and the Role of Gleason Score in Surgical Treatment Decision-Making. 前列腺病变的组织病理学特征及Gleason评分在手术治疗决策中的作用。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3212
Mihai-Cătălin Roşu, Cristina Anita Ionescu, Manuela Enciu, Bogdan Cã Mpineanu, Mihaela Pundiche, Nicolae Dobrin, Ionuà Iorga, Mariana Deacu, Oana Cojocaru, Ionuţ Burlacu, Miruna-Gabriela Vizireanu, Anca Chisoi, Ionuţ Poinareanu, Lucian Cristian Petcu

Introduction: The Gleason score plays a key role in risk stratification and surgical treatment selection for prostate cancer. This study evaluates the correlation between Gleason score, patient age, and tumor aggressiveness, with implications for medical practice. Methods: This retrospective study included 215 patients from Sf. Apostol Andrei Clinical Emergency Hospital of Constanta County (2023-2024) with histopathologically confirmed prostate lesions. Demographic variables (age), Gleason score (classified according to ISUP 2019), and histological grade were analyzed. Data were statistically analyzed using t tests, ANOVA, and logistic regression. While international guidelines provide a standardized framework for management, local and regional variations in healthcare access, diagnostic pathways, and patient preferences significantly influence real-world clinical practice. This study aims to describe the histopathological spectrum of prostatic lesions and evaluate the prognostic relevance of the Gleason score in surgical decision-making within the specific context of a Romanian tertiary care center. By highlighting regional particularities, such as the high burden of aggressive disease and the challenges in implementing active surveillance, our findings contribute to a more nuanced understanding of global prostate cancer care. Results: Benign prostatic hyperplasia (BPH) accounted for 42.8% of cases, PCa for 44.7%, and urothelial carcinoma for 8.4%. Among prostate cancers, 87.5% had clinically significant disease (Gleason >=7), with 29.2% high-risk (Gleason 8-10). Gleason 7 was most frequent (58.3%), predominantly 3+4. A significant correlation was observed between advanced age ( >70 years) and tumor aggressiveness (OR = 2.3; 95% CI: 1.4-3.8). Radical prostatectomy was primarily chosen for Gleason scores >=7, with higher complication rates in older patients. Conclusions: Advanced age and a high Gleason score are independent factors of tumor aggressiveness. Early surgical intervention in patients with Gleason >=7 improves oncological outcomes. Integrating histopathology with multiparametric MRI and molecular biomarkers could optimize management of these patients.

Gleason评分在前列腺癌的风险分层和手术治疗选择中起着关键作用。本研究评估Gleason评分、患者年龄和肿瘤侵袭性之间的相关性,并对医疗实践具有指导意义。方法:本回顾性研究纳入215例Sf患者。康斯坦察县Apostol Andrei临床急诊医院(2023-2024),组织病理学证实前列腺病变。分析人口统计学变量(年龄)、Gleason评分(根据ISUP 2019分类)和组织学分级。数据采用t检验、方差分析和逻辑回归进行统计分析。虽然国际准则为管理提供了标准化框架,但当地和地区在医疗保健获取、诊断途径和患者偏好方面的差异显著影响着现实世界的临床实践。本研究旨在描述前列腺病变的组织病理学谱,并在罗马尼亚三级护理中心的特定背景下评估格里森评分在手术决策中的预后相关性。通过强调区域特殊性,如侵袭性疾病的高负担和实施主动监测的挑战,我们的研究结果有助于更细致地了解全球前列腺癌护理。结果:良性前列腺增生占42.8%,前列腺癌占44.7%,尿路上皮癌占8.4%。在前列腺癌中,87.5%有临床显著性病变(Gleason Ãⅱ?Â¥7),高风险29.2% (Gleason 8â?”10)。Gleason 7最常见(58.3%),以3+4型为主。高龄(70岁)与肿瘤侵袭性之间存在显著相关性(OR = 2.3; 95% CI: 1.4-3.8)。根治性前列腺切除术主要选择Gleason评分â?Â¥7,老年患者并发症发生率较高。结论:高龄和高格里森评分是影响肿瘤侵袭性的独立因素。Gleason患者的早期手术干预Ãⅱ?Â¥7改善肿瘤预后。将组织病理学与多参数MRI和分子生物标志物相结合可以优化这些患者的管理。
{"title":"Histopathological Profile of Prostatic Lesions and the Role of Gleason Score in Surgical Treatment Decision-Making.","authors":"Mihai-Cătălin Roşu, Cristina Anita Ionescu, Manuela Enciu, Bogdan Cã Mpineanu, Mihaela Pundiche, Nicolae Dobrin, Ionuà Iorga, Mariana Deacu, Oana Cojocaru, Ionuţ Burlacu, Miruna-Gabriela Vizireanu, Anca Chisoi, Ionuţ Poinareanu, Lucian Cristian Petcu","doi":"10.21614/chirurgia.3212","DOIUrl":"10.21614/chirurgia.3212","url":null,"abstract":"<p><p><b>Introduction:</b> The Gleason score plays a key role in risk stratification and surgical treatment selection for prostate cancer. This study evaluates the correlation between Gleason score, patient age, and tumor aggressiveness, with implications for medical practice. \u0000<b>Methods:</b> This retrospective study included 215 patients from Sf. Apostol Andrei Clinical Emergency Hospital of Constanta County (2023-2024) with histopathologically confirmed prostate lesions. Demographic variables (age), Gleason score (classified according to ISUP 2019), and histological grade were analyzed. Data were statistically analyzed using t tests, ANOVA, and logistic regression. While international guidelines provide a standardized framework for management, local and regional variations in healthcare access, diagnostic pathways, and patient preferences significantly influence real-world clinical practice. This study aims to describe the histopathological spectrum of prostatic lesions and evaluate the prognostic relevance of the Gleason score in surgical decision-making within the specific context of a Romanian tertiary care center. By highlighting regional particularities, such as the high burden of aggressive disease and the challenges in implementing active surveillance, our findings contribute to a more nuanced understanding of global prostate cancer care. \u0000<b>Results:</b> Benign prostatic hyperplasia (BPH) accounted for 42.8% of cases, PCa for 44.7%, and urothelial carcinoma for 8.4%. Among prostate cancers, 87.5% had clinically significant disease (Gleason >=7), with 29.2% high-risk (Gleason 8-10). Gleason 7 was most frequent (58.3%), predominantly 3+4. A significant correlation was observed between advanced age ( >70 years) and tumor aggressiveness (OR = 2.3; 95% CI: 1.4-3.8). Radical prostatectomy was primarily chosen for Gleason scores >=7, with higher complication rates in older patients. \u0000<b>Conclusions:</b> Advanced age and a high Gleason score are independent factors of tumor aggressiveness. Early surgical intervention in patients with Gleason >=7 improves oncological outcomes. Integrating histopathology with multiparametric MRI and molecular biomarkers could optimize management of these patients.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"593-602"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Outcomes of Patients with Acute Mesenteric Ischaemia in a Retrospective Study. 一项回顾性研究急性肠系膜缺血患者的临床特征和预后。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3127
Giuseppe Evola, Marco Vacante, Francesco Roberto Evola, Martina Barchitta, Grazia Maugeri, Giuseppe Musumeci, Velia D'Agata, Guido Basile

Background: Intestinal ischaemia is an abdominal emergency characterized by a drastic reduction in blood flow in the mesenteric vessels with the possible onset of necrosis of the small intestine and/or colon. Its incidence is rather rare and the diagnosis is very difficult as the clinical presentation is not specific and there are no pathognomonic laboratory tests. Methods: A retrospective study was carried out on 28 patients with intestinal infarction, including analysis of the risk factors, comorbidities, symptoms, laboratory tests and instrumental investigations, to determine the presence of eventual signs of mesenteric ischaemia secondary to vascular insufficiency. Results: Twenty-four patients (85%) underwent surgery and intestinal necrosis was found in all. Among these, a quite high mortality rate (64%) was observed. Conclusion: The retrospective study confirmed the low frequency, high mortality and diagnostic difficulty of mesenteric ischaemia in its various clinical forms. Currently, there are neither laboratory tests nor instrumental techniques that can give a certain diagnosis of acute mesenteric ischaemia in an early phase. However, strong clinical suspicion, a rapid diagnosis and an aggressive therapeutic approach could improve the clinical results and reduce its high mortality.

背景:肠缺血是一种腹部急症,其特征是肠系膜血管血流急剧减少,可能出现小肠和/或结肠坏死。它的发病率是相当罕见的,诊断是非常困难的,因为临床表现不明确,没有病理特征的实验室检查。方法:回顾性分析28例肠梗死患者的危险因素、合并症、症状、实验室检查和仪器检查,以确定是否存在继发于血管不全的肠系膜缺血的最终体征。结果:24例(85%)患者行手术治疗,全部发现肠坏死。其中,死亡率相当高(64%)。结论:回顾性研究证实了肠系膜缺血性各种临床表现的发生率低、死亡率高、诊断困难等特点。目前,既没有实验室检查,也没有仪器技术可以在早期阶段对急性肠系膜缺血做出一定的诊断。然而,强烈的临床怀疑,快速的诊断和积极的治疗方法可以改善临床效果,降低其高死亡率。
{"title":"Clinical Features and Outcomes of Patients with Acute Mesenteric Ischaemia in a Retrospective Study.","authors":"Giuseppe Evola, Marco Vacante, Francesco Roberto Evola, Martina Barchitta, Grazia Maugeri, Giuseppe Musumeci, Velia D'Agata, Guido Basile","doi":"10.21614/chirurgia.3127","DOIUrl":"10.21614/chirurgia.3127","url":null,"abstract":"<p><p><b>Background:</b> Intestinal ischaemia is an abdominal emergency characterized by a drastic reduction in blood flow in the mesenteric vessels with the possible onset of necrosis of the small intestine and/or colon. Its incidence is rather rare and the diagnosis is very difficult as the clinical presentation is not specific and there are no pathognomonic laboratory tests. \u0000<b>Methods:</b> A retrospective study was carried out on 28 patients with intestinal infarction, including analysis of the risk factors, comorbidities, symptoms, laboratory tests and instrumental investigations, to determine the presence of eventual signs of mesenteric ischaemia secondary to vascular insufficiency. \u0000<b>Results:</b> Twenty-four patients (85%) underwent surgery and intestinal necrosis was found in all. Among these, a quite high mortality rate (64%) was observed. \u0000<b>Conclusion:</b> The retrospective study confirmed the low frequency, high mortality and diagnostic difficulty of mesenteric ischaemia in its various clinical forms. Currently, there are neither laboratory tests nor instrumental techniques that can give a certain diagnosis of acute mesenteric ischaemia in an early phase. However, strong clinical suspicion, a rapid diagnosis and an aggressive therapeutic approach could improve the clinical results and reduce its high mortality.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 Ahead of print","pages":"1-10"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145376652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Nutritional and Immune Status using the Conut Score in Patients Undergoing Billroth I and Billroth II / Roux-en-Y Reconstruction. 使用椰子评分对Billroth I和Billroth II / Roux-en-Y重建患者营养和免疫状况的比较分析。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3218
Cătălin Cosma, Vlad Olimpiu Butiurca, Cosmin Nicolescu, Paul Cristian Russu, Marian Botoncea, Călin Molnar

Background: Gastric cancer surgery requires not only oncological radicality but also functional reconstruction. Billroth I remains the most physiological method of restoring continuity, whereas Billroth II and Roux-en-Y are most frequently adopted in the oncological treatment. Nutritional and immune competence strongly influence postoperative outcomes, and the Controlling Nutritional Status (CONUT) score has emerged as a validated biomarker integrating albumin, lymphocyte count, and cholesterol in predicting complications in surgically treated patients. Methods: We conducted a prospective observational single-center study including 150 patients undergoing curative distal gastrectomy between October 2021 and December 2024. Reconstruction was performed using Billroth I (n=72) or Billroth II/Roux-en-Y (n=78). The CONUT score was assessed preoperatively (T0), early postoperatively (T1), and at three months (T2). Outcomes included CONUT evolution, postoperative complications (Clavien Dindo), length of stay, readmission, and mortality. Results: Both reconstruction groups demonstrated a significant postoperative increase in CONUT score (median 2 [1-3] at T0 to 3 [2-4] at T1, p 0.001), followed by partial recovery at three months. No differences were observed between Billroth I and Billroth II/Roux-en-Y at any timepoint. Higher CONUT values at T0, T1, and T2 independently predicted overall and major complications (OR range 1.15 1.25, p 0.05). Postoperative morbidity, mortality (3.3%), and hospital stay were similar across groups. Conclusions: The CONUT score is an independent predictor of perioperative morbidity in gastric cancer, while the choice of reconstruction method does not significantly alter immunonutritional trajectories. Serial CONUT monitoring may enhance perioperative risk stratification.

背景:胃癌手术不仅需要肿瘤根治,还需要功能重建。Billroth I仍然是恢复连续性最生理的方法,而Billroth II和Roux-en-Y最常用于肿瘤治疗。营养和免疫能力强烈影响术后预后,控制营养状态(CONUT)评分已成为一种有效的生物标志物,可整合白蛋白、淋巴细胞计数和胆固醇,预测手术治疗患者的并发症。方法:我们进行了一项前瞻性观察性单中心研究,包括150例在2021年10月至2024年12月期间接受根治性胃远端切除术的患者。采用Billroth I (n=72)或Billroth II/Roux-en-Y (n=78)进行重建。术前(T0)、术后早期(T1)和术后3个月(T2)评估CONUT评分。结果包括CONUT演变、术后并发症(Clavienâ?(Dindo)、住院时间、再入院和死亡率。结果:两个重建组术后CONUT评分均显著升高(T0时中位数为2 [1-3],T1时中位数为3 [2-4],p 0.001), 3个月时部分恢复。Billroth I和Billroth II/Roux-en-Y在任何时间点均无差异。T0、T1和T2时较高的CONUT值独立预测了总体并发症和主要并发症(OR范围:1.15à 0.01 ~ 1.25, p 0.05)。两组术后发病率、死亡率(3.3%)和住院时间相似。结论:CONUT评分是胃癌围手术期发病率的独立预测指标,而重建方法的选择并没有显著改变免疫营养轨迹。连续CONUT监测可加强围手术期风险分层。
{"title":"Comparative Analysis of Nutritional and Immune Status using the Conut Score in Patients Undergoing Billroth I and Billroth II / Roux-en-Y Reconstruction.","authors":"Cătălin Cosma, Vlad Olimpiu Butiurca, Cosmin Nicolescu, Paul Cristian Russu, Marian Botoncea, Călin Molnar","doi":"10.21614/chirurgia.3218","DOIUrl":"10.21614/chirurgia.3218","url":null,"abstract":"<p><p><b>Background:</b> Gastric cancer surgery requires not only oncological radicality but also functional reconstruction. Billroth I remains the most physiological method of restoring continuity, whereas Billroth II and Roux-en-Y are most frequently adopted in the oncological treatment. Nutritional and immune competence strongly influence postoperative outcomes, and the Controlling Nutritional Status (CONUT) score has emerged as a validated biomarker integrating albumin, lymphocyte count, and cholesterol in predicting complications in surgically treated patients. \u0000<b>Methods:</b> We conducted a prospective observational single-center study including 150 patients undergoing curative distal gastrectomy between October 2021 and December 2024. Reconstruction was performed using Billroth I (n=72) or Billroth II/Roux-en-Y (n=78). The CONUT score was assessed preoperatively (T0), early postoperatively (T1), and at three months (T2). Outcomes included CONUT evolution, postoperative complications (Clavien Dindo), length of stay, readmission, and mortality. \u0000<b>Results:</b> Both reconstruction groups demonstrated a significant postoperative increase in CONUT score (median 2 [1-3] at T0 to 3 [2-4] at T1, p 0.001), followed by partial recovery at three months. No differences were observed between Billroth I and Billroth II/Roux-en-Y at any timepoint. Higher CONUT values at T0, T1, and T2 independently predicted overall and major complications (OR range 1.15 1.25, p 0.05). Postoperative morbidity, mortality (3.3%), and hospital stay were similar across groups. \u0000<b>Conclusions:</b> The CONUT score is an independent predictor of perioperative morbidity in gastric cancer, while the choice of reconstruction method does not significantly alter immunonutritional trajectories. Serial CONUT monitoring may enhance perioperative risk stratification.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"566-574"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Outcomes in Hepatocellular Carcinoma Surgery: ALBI is the Better Tool. An Observational Cohort Study. 预测肝细胞癌手术预后:ALBI是更好的工具观察性队列研究。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3146
Raluca Zaharia, Stefan Morarasu, Andreea Antonina Ivanov, Gabriel Mihail Dimofte, Sorinel Lunca

Background: Hepatic resection is a key curative option for hepatocellular carcinoma (HCC), but postoperative morbidity and early mortality remain significant concerns, especially in patients with impaired liver function. Accurate preoperative risk stratification is essential to improve outcomes. This study compares the predictive value of three liver function scores - MELD, ALBI, and Child-Pugh - for postoperative morbidity and 30-day mortality. Methods: A retrospective study was conducted on 55 patients who underwent hepatic resection for HCC between 2013 and 2024 at a single tertiary center. Preoperative MELD, ALBI, and Child-Pugh scores were calculated and analyzed in relation to postoperative complications and mortality. Diagnostic performance was assessed using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and ROC curves. Results: Postoperative morbidity occurred in 23.6% of patients, with a 30-day mortality rate of 9.1%. The ALBI score showed the highest specificity (73.8%) and NPV (81.6%) for morbidity prediction. It also demonstrated perfect sensitivity (100%) and NPV (100%) for post-hepatectomy liver failure (PHLF), with an AUC of 0.85. Patients with ALBI Grade 1 had fewer complications and shorter hospital stays. MELD showed moderate predictive value, particularly in ruling out mortality. The Child-Pugh score had the weakest performance, primarily due to low sensitivity. Conclusion: ALBI is the most accurate and objective score for identifying high-risk patients undergoing liver resection for HCC. MELD provides additional value in mortality exclusion. The limited sensitivity of Child-Pugh suggests it should be used with caution. Incorporating ALBI into preoperative assessment may enhance surgical decision-making and risk stratification.

背景:肝切除术是肝细胞癌(HCC)的关键治疗选择,但术后发病率和早期死亡率仍然值得关注,特别是对肝功能受损的患者。准确的术前风险分层对改善预后至关重要。这项研究比较了三种肝功能评分的预测价值â?MELD, ALBI和Child-Pugh Ù”的术后发病率和30天死亡率。方法:回顾性研究2013 - 2024年间在某三级中心行肝切除术的55例HCC患者。计算并分析术前MELD、ALBI和Child-Pugh评分与术后并发症和死亡率的关系。采用敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和ROC曲线评估诊断效果。结果:术后发病率为23.6%,30天死亡率为9.1%。ALBI评分在预测发病率方面具有最高的特异性(73.8%)和NPV(81.6%)。该方法对肝切除术后肝衰竭(PHLF)的敏感性(100%)和NPV(100%)均达到完美,AUC为0.85。1级ALBI患者并发症较少,住院时间较短。MELD具有中等的预测价值,特别是在排除死亡率方面。Child-Pugh评分表现最差,主要是由于灵敏度低。结论:ALBI评分是鉴别HCC肝切除术高危患者最准确、客观的评分方法。MELD在死亡率排除方面提供了额外的价值。Child-Pugh的有限敏感性表明,应谨慎使用。将ALBI纳入术前评估可提高手术决策和风险分层。
{"title":"Predicting Outcomes in Hepatocellular Carcinoma Surgery: ALBI is the Better Tool. An Observational Cohort Study.","authors":"Raluca Zaharia, Stefan Morarasu, Andreea Antonina Ivanov, Gabriel Mihail Dimofte, Sorinel Lunca","doi":"10.21614/chirurgia.3146","DOIUrl":"10.21614/chirurgia.3146","url":null,"abstract":"<p><p><b>Background:</b> Hepatic resection is a key curative option for hepatocellular carcinoma (HCC), but postoperative morbidity and early mortality remain significant concerns, especially in patients with impaired liver function. Accurate preoperative risk stratification is essential to improve outcomes. This study compares the predictive value of three liver function scores - MELD, ALBI, and Child-Pugh - for postoperative morbidity and 30-day mortality. \u0000<b>Methods:</b> A retrospective study was conducted on 55 patients who underwent hepatic resection for HCC between 2013 and 2024 at a single tertiary center. Preoperative MELD, ALBI, and Child-Pugh scores were calculated and analyzed in relation to postoperative complications and mortality. Diagnostic performance was assessed using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and ROC curves. \u0000<b>Results:</b> Postoperative morbidity occurred in 23.6% of patients, with a 30-day mortality rate of 9.1%. The ALBI score showed the highest specificity (73.8%) and NPV (81.6%) for morbidity prediction. It also demonstrated perfect sensitivity (100%) and NPV (100%) for post-hepatectomy liver failure (PHLF), with an AUC of 0.85. Patients with ALBI Grade 1 had fewer complications and shorter hospital stays. MELD showed moderate predictive value, particularly in ruling out mortality. The Child-Pugh score had the weakest performance, primarily due to low sensitivity. \u0000<b>Conclusion:</b> ALBI is the most accurate and objective score for identifying high-risk patients undergoing liver resection for HCC. MELD provides additional value in mortality exclusion. The limited sensitivity of Child-Pugh suggests it should be used with caution. Incorporating ALBI into preoperative assessment may enhance surgical decision-making and risk stratification.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"555-565"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Augmented Reality Integration for Surgical Enhancement in Hepatic Surgery - Review of the Current Literature. 增强现实集成在肝脏外科手术增强-当前文献综述。
IF 0.8 Q4 SURGERY Pub Date : 2025-10-01 DOI: 10.21614/chirurgia.3115
David Andraş, Radu Alexandru Ilieş, Alexandru Ilie-Ene, Victor Eşanu, Vasile Binţinţan, George Dindelegan

Background: Intrahepatic anatomy remains a challenge in mini-invasive liver surgery. Augmented Reality (AR), which integrates digital information with the user's environment, can benefit liver surgery by improving tumor and vessel positioning, resection planning, and surgical training. This review highlights AR's applications in liver surgery.

Methods: Articles published from 2010-2024 on PubMed using keywords ("Augmented Reality" AND "Liver Surgery") OR ("Navigation" AND "Liver Surgery") were analyzed. 32 articles assessing AR's accuracy, safety, operative time, and training impact were included.

Results: AR in Image-Guided Surgery (IGS) combines 3D reconstructions (e.g., CT scans) with laparoscopic images, enhancing the understanding of the surgical site. AR aids in margin planning, lesion boundary setting, and accurate hemostasis. It improves oncological outcomes, reduces errors, increases accuracy, and sometimes shortens surgery time. AR also enhances surgical training by accelerating skill acquisition and reducing the learning curve. However, more data is needed to standardize AR techniques.

Conclusion: AR can significantly enhance mini-invasive liver surgery by improving precision, safety, efficiency, and training. While further research is necessary to standardize techniques, AR holds great potential for improving surgical outcomes and training quality.

背景:在微创肝手术中,肝内解剖仍然是一个挑战。增强现实(AR)将数字信息与用户的环境相结合,可以通过改善肿瘤和血管定位、切除计划和手术培训来造福肝脏手术。本文综述了AR在肝脏手术中的应用。方法:2010-2024年在PubMed上发表的论文,关键词:â??增强RealityA¢吗?Â和â??肝脏SurgeryA¢吗?Â) OR (â??Navigationâ?Â和â??肝脏SurgeryA¢吗?Â)进行分析。纳入了32篇评估AR的准确性、安全性、手术时间和培训影响的文章。结果:图像引导手术(IGS)中的AR将3D重建(如CT扫描)与腹腔镜图像相结合,增强了对手术部位的理解。AR有助于边缘规划、病灶边界设置和准确止血。它改善了肿瘤预后,减少了错误,提高了准确性,有时还缩短了手术时间。AR还通过加速技能获取和缩短学习曲线来加强外科培训。然而,标准化AR技术还需要更多的数据。结论:AR可提高微创肝手术的精度、安全性、效率和训练水平。虽然需要进一步的研究来标准化技术,但AR在改善手术结果和培训质量方面具有巨大的潜力。
{"title":"Augmented Reality Integration for Surgical Enhancement in Hepatic Surgery - Review of the Current Literature.","authors":"David Andraş, Radu Alexandru Ilieş, Alexandru Ilie-Ene, Victor Eşanu, Vasile Binţinţan, George Dindelegan","doi":"10.21614/chirurgia.3115","DOIUrl":"10.21614/chirurgia.3115","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic anatomy remains a challenge in mini-invasive liver surgery. Augmented Reality (AR), which integrates digital information with the user's environment, can benefit liver surgery by improving tumor and vessel positioning, resection planning, and surgical training. This review highlights AR's applications in liver surgery.</p><p><strong>Methods: </strong>Articles published from 2010-2024 on PubMed using keywords (\"Augmented Reality\" AND \"Liver Surgery\") OR (\"Navigation\" AND \"Liver Surgery\") were analyzed. 32 articles assessing AR's accuracy, safety, operative time, and training impact were included.</p><p><strong>Results: </strong>AR in Image-Guided Surgery (IGS) combines 3D reconstructions (e.g., CT scans) with laparoscopic images, enhancing the understanding of the surgical site. AR aids in margin planning, lesion boundary setting, and accurate hemostasis. It improves oncological outcomes, reduces errors, increases accuracy, and sometimes shortens surgery time. AR also enhances surgical training by accelerating skill acquisition and reducing the learning curve. However, more data is needed to standardize AR techniques.</p><p><strong>Conclusion: </strong>AR can significantly enhance mini-invasive liver surgery by improving precision, safety, efficiency, and training. While further research is necessary to standardize techniques, AR holds great potential for improving surgical outcomes and training quality.</p>","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"120 5","pages":"491-501"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chirurgia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1